← FDA Drug Approvals (Drugs@FDA)
METRONIDAZOLE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2024-12-31
Drug application
- FDA Application #
ANDA216750- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- METRONIDAZOLE
- Generic name
- METRONIDAZOLE
- Active ingredients
- METRONIDAZOLE
- Dosage form
- GEL
- Route
- VAGINAL
- Marketing status
- Prescription
- Sponsor
- SCIEGEN PHARMS
- Manufacturer
- Saptalis Pharmaceuticals LLC
- First approval
- 2024-12-31
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown